Skip to main content
    T

    Tvardi Therapeutics, Inc. (TVRD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.01
    -0.09 (-8.18%)

    Market Cap: $14.70M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Tvardi Therapeutics, Inc. (TVRD) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Tvardi Therapeutics (TVRD) has a market cap of $14.70M. Its share count is up 34.94% from a year earlier. It holds $22.27M more cash than debt, 151.53% of its market cap.

    Total Valuation

    Market Cap$14.70M
    Latest price (Nov 17, 2026)$1.01

    Key Dates

    The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 29, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 34.88% in the quarter ended Sep 30, 2026.

    Shares Outstanding12.65M
    Shares Change (YoY)+34.94%
    Shares Change (QoQ)+34.88%

    Valuation Ratios

    P/B Ratio0.8x
    P/TBV Ratio0.8x

    Price Statistics

    The stock is down 74.94% over 52 weeks and trades 15.83% below its 50-day average.

    Beta (1Y)1.81
    52-Week Change-74.94%
    1-Month Change+4.12%
    3-Month Change-46.28%
    6-Month Change-72.78%
    5-Year Change-99.87%
    10-Year Change-99.69%
    Total Return (1Y)-74.94%
    Total Return (3Y CAGR)-70.56%
    Total Return (5Y CAGR)-71.34%
    Return vs SPY (1Y)-87.04%
    Max Drawdown (1Y)-84.14%
    Max Drawdown (3Y)-98.24%
    Sharpe Ratio (1Y)-1.16
    Correlation with SPY (1Y)0.20
    50-Day Average$1.20
    200-Day Average$2.56
    52-Week Range$0.77 to $5.69
    RSI (14 Days)45.5
    Average Volume (20 Days)365.95K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.86x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio2.86x
    Quick Ratio2.86x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -202.72% and return on assets is -133.14% over the last 12 months.

    Return on Equity (ROE)-202.72%
    Return on Assets (ROA)-133.14%
    Return on Capital Employed (ROCE)-191.27%
    ROA (5Y Average)-63.44%

    Scores

    TVRD has an Altman Z-Score of -10.26, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Altman Z-Score-10.26
    Altman Z ZoneDistress
    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was -$2.57M over the last 12 months.

    Revenue-$2.57M
    Gross Profit-$2.57M
    Operating Income-$29.56M
    Pretax Income-$38.49M
    Net Income-$31.33M
    EBITDA-$29.55M
    EBIT-$29.56M
    Reported EPS (TTM)-$2.68

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 65.70% of the $23.53M in total assets.

    Cash and Equivalents$22.27M
    Total Debt$0
    Net Cash$22.27M
    Net Cash Per Share$1.76
    Working Capital$15.05M
    Shareholder Equity$15.46M
    Book Value Per Share$1.22
    Tangible Book Value$15.18M
    Tangible Book Per Share$1.20
    Total Assets$23.53M
    Total Liabilities$8.08M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$27.15M
    FCF Per Share-$2.04
    Depreciation and Amortization$178.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Stock Splits

    The last split was a 1-for-3 reverse split on Apr 16, 2025.

    Last Split DateApr 16, 2025
    Split TypeReverse split
    Split Ratio1:3

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About TVRD

    What is TVRD's market cap?

    Tvardi Therapeutics has a market cap of $14.70M.

    How many shares of TVRD are outstanding?

    Tvardi Therapeutics has 12.65M shares outstanding. The count is up 34.94% from a year earlier.

    Does TVRD pay a dividend?

    No. Tvardi Therapeutics does not pay a dividend.

    How much debt does TVRD have?

    Tvardi Therapeutics has $0 of total debt and $22.27M of cash and equivalents, a net cash position of $22.27M.